secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001493152-24-024108
Event type: leadership
Sentiment:  positive
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte appoints Andrea James as CFO, effective June 17, 2024
--------------------------------------------------------------

- Andrea James appointed CFO; previously Chief Communications Officer at Axon Enterprise (AXON) and IR roles at Tesla.
- Compensation: $325,000 base salary, 50% target bonus; option for 200,000 shares and 100,000 RSUs (subject to shareholder approval).
- CEO Josh Riggs cites James' experience in capital raising and IR as company nears commercial launch.
- James Liu remains Senior Director, Controller & Principal Accounting Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315224024108/0001493152-24-024108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315224024108/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer